MedTrace Logo

Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular Edema

NCT00994955 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2013-01-16

No results posted yet for this study

Summary

Selective Retina Therapy (SRT) is an effective and safe laser treatment of clinically significant diabetic macular edema which targets the retinal pigment epithelium while sparing the neurosensory retina.

Conditions

Interventions

DEVICE

selective retina therapy (SRT)

laser treatment

Sponsors & Collaborators

  • Medical Laser Center Lübeck, Germany

    collaborator UNKNOWN

  • St Thomas

    collaborator AMBIG

  • University Hospital Schleswig-Holstein

    lead OTHER

Principal Investigators

  • Jost Hillenkamp, MD · Dept. of Ophthalmology, University Medical Center Schleswig-Holstein, Kiel Campus

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2008-12-31
Completion
2009-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00994955 on ClinicalTrials.gov